The Aperlena Verdict
Open raceNo supplier dominates: 132 different companies have won the last 305 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- -52.7%
- Expected final price vs the published estimate
Based on 305 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis public tender concerns recurring supplies of medicinal products containing the active substance imatinib. Imatinib belongs to the group of antineoplastic and immunomodulating medicines used in targeted cancer therapy. The contracting authority will procure these medicines through repeated deliveries over the duration of the contract, covering the needs arising during 2026 as indicated in the tender title. Suppliers are expected to deliver the medicinal products in the required pack sizes and quantities according to call-off orders placed during the contract period. The tender covers medicines with imatinib as the active substance only, without additional lots or related services being described in the notice text.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 20 hours ago
More from this buyer
Full buyer profile44 open tenders right now
- Antivirals for systemic use - LP containing letermovir 2026 1 day left
- Czech Republic - Construction modifications of healthcare facilities - Building works for buildings H1 and H2 1 day left
- Czech Republic - Architectural, construction, engineering and inspection services - PD - Building Permit Design for Buildings A and D 1 day left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Alliance Healthcare s.r.o. | 29 | €17.8M | Sep 2026 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 28 | €19.3M | Aug 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 12 | €5.1M | Sep 2026 |
| PHARMOS, a.s. | 12 | €4.9M | Jun 2026 |
| Boston Scientific Česká republika s.r.o. | 10 | €3.5M | Aug 2026 |
Based on 305 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 308 comparable contracts this buyer awarded in this sector over the last 4 years.
- €83,225
- Lower quartile
- €188,017
- Median award
- €618,096
- Upper quartile
This tender is estimated 0.4% above that median
Most recent awards
- Česko - Antineoplastika - LP s obsahem pirtobrutinibu 2026 €644,580
- Česko - Antineoplastika - LP s obsahem izatuximabu 2026 €1,953,942
- Czech Republic - Medicinal products and medical devices - Dynamic purchasing system for the supply of medicinal products €207,999
- Česko - Kanyly - Kanyly k oxygenátorům €33,183
- Česko - Chirurgické implantáty - Implantát k léčbě prolapsu pánevního dna €60,694
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€414,027
est. value
1
day left
€288,329
est. value
1
day left
€5,769,865
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,152,710
- Buyer track record on Aperlena
- 774 notices tracked · 410 awarded
- €680,926,732 in awarded contracts
Never miss a tender like this
170 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert